We report that highly purified human platelet factor 4 (PF4) inhibits human megakaryocytopoiesis in vitro. At 2 25 gg/ml, PF4 inhibited megakaryocyte colony formation -80% in unstimulated cultures, and -58% in cultures containing recombinant human IL 3 and granulocyte-macrophage colony-stimulating factor. Because PF4 (25 gg/ml) had no effect on either myeloid or erythroid colony formation lineage specificity of this effect was suggested. A synthetic COOH-terminal PF4 peptide of 24, but not 13 residues, also inhibited megakaryocyte colony formation, whereas a synthetic 18-residue fithromboglobulin (,f-TG) peptide and native fl-TG had no such effect when assayed at similar concentrations. The mechanism of PF4-mediated inhibition was investigated. First, we enumerated total cell number, and examined cell maturation in control colonies (n = 200) and colonies (n = 100) that arose in PF4-containing cultures. Total cells per colony did not differ dramatically in the two groups (6.1±3.0 vs. 4.2±1.6, respectively), but the numbers of mature large cells per colony was significantly decreased in the presence of PF4 when compared with controls (1.6±1.5 vs. 3.9±2.3; P < 0.001). Second, by using the human leukemia cell line HEL as a model for primitive megakaryocytic cells, we studied the effect of PF4 on cell doubling time, on the expression of both growth-regulated (H3, p53, c-myc, and c-myb), and non-growth-regulated (fi2-microglobulin) genes. At high concentrations of native PF4 (50 ,gg/ml), no effect on cell doubling time, or H3 or p53 expression was discerned. In contrast, c-myc and c-myb were both upregulated. These results suggested the PF4 inhibited colony formation by impeding cell maturation, as opposed to cell proliferation, perhaps by inducing expression of c-myc and c-myb.
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The ability of PF4 to inhibit a normal cell maturation function was then tested. Megakaryocytes were incubated in synthetic PF4, or ,B-TG peptides for 18 h and effect on Factor V steadystate mRNA levels was determined in 600 individual cells by in situ hybridization. fl-TG peptide had no effect on FV mRNA levels, whereas a -60% decrease in expression of Factor V mRNA was found in megakaryocytes exposed to 2 100 ng/ml synthetic COOH-terminal PF4 peptide. Accordingly, PF4 modulates megakaryocyte maturation in vitro, and may func-
Introduction
Human megakaryocytopoiesis is a complex, highly regulated process whose study has been greatly facilitated by the advent of in vitro culture systems (1) . With this tool, the existence of several positive, though not necessarily lineage specific, growth-enhancing molecules has been demonstrated. Such proliferation and/or maturation promoting activities include megakaryocyte colony-stimulating factor (Meg-CSF)l (2) , granulocyte-macrophage colony-stimulating factor (GM-CSF) (3) , IL 3 (4) , thrombopoietin (TPO) (5, 6) , megakaryocyte stimulatory factor (MSF) (7, 8) , and erythropoietin (9) .
Potential inhibitors of megakaryocytopoiesis have been less well studied. Immunocytes, and their products, have been documented to cause clinically significant suppression of megakaryocyte production (10, 1 1) , but the role of such cells in the day-to-day regulation of megakaryocyte development and platelet release remains speculative (12). Several groups have provided evidence that megakaryocyte colony growth is inferior in serum when compared with growth in platelet-poor plasma (13) (14) (15) suggesting that platelet constituents can inhibit megakaryocytopoiesis in vitro. Studies from our group have shown that megakaryocyte products have a similar capability (16, 17) . These observations raise the possibility that human megakaryocytopoiesis may also be under the control of feedback or negative autocrine regulators.
The nature of the putative megakaryocyte/platelet constituent(s) involved in this form of autoregulation remains poorly defined. It has recently been reported that transforming growth factor-,B (TGF-fl) inhibits megakaryocytopoiesis in vitro (I18-20). However, because TGF-,B is widely distributed, is not known to be synthesized by megakaryocytes, and inhibits the growth of many other hematopoietic cell lineages, the physiologic relevance of this observation remains unclear (18) . An incompletely characterized 12-1 7-kD secreted platelet glycoprotein has also been identified as an autocrine regulator (2 1).
Platelet factor 4 (PF4) is a megakaryocyte/platelet-specific a granule protein. In the granule it exists as a tetramer, composed of identical 7,800-kD monomers (22, 23) . When platelets are activated, the protein is extruded from the a granule complexed with a high-molecular weight proteoglycan (24) . Subsequently, the complex is rapidly cleared from the circula-tion, perhaps by binding of the protein to endothelial surfaces and hepatocytes (25) .
A number of biological activities have been attributed to PF4. It neutralizes heparin (26) , has the ability to stimulate leukocyte elastase activity (27) and inhibit collagenase activity (28), and is chemotactic for neutrophils, monocytes, and fibroblasts (21, 29 clear/cytoplasmic ratio similar to that of lymphocytes and/or other undifferentiated mononuclear cells in the clot, and (c) if no nuclear lobation was present when viewed under phase conditions. Large mature megakaryocytes in colonies were defined as cells which (a) had diameter > 10 jm, (b) had a lower nuclear/cytoplasmic ratio than that used to characterize small cells, or (c) had identifiable nuclear lobation under fluorescent or phase microscopy.
CFU-E-(colony forming unit-erythroid) derived colony growth was stimulated by either aplastic anemia serum, or recombinant human erythropoietin (Amgen Corp., Thousand Oaks, CA). Colonyforming unit granulocyte-macrophage-(CFU-GM) derived colonies were stimulated by IL 3 and GM-CSF. Colonies were identified as previously described (1 1).
Isolation of mature marrow megakaryocytes. Mature (morphologically recognizable) megakaryocytes were isolated from the marrow of normal bone marrow donors by the process ofcounterflow centrifugal elutriation as previously described (37, 38 Thomas (41) . DNA probes were labeled at high specific activity by random priming essentially as described by Feinberg and Vogelstein (42) . Prehybridization, hybridization, and posthybridization washes were done essentially as described by Wahl et al. (43) . Autoradiography was performed by exposing filters on x-ray film (Eastman-Kodak) at -70'C using intensifying screens.
In situ hybridization was performed using a synthesis of the techniques described by Brigati et al. (44) , Lum (45) , and Singer et al. (46) . Human megakaryocytes, fixed and stored as described above, were deposited onto glass slides by cytocentrifugation (500 rpm for 8 min, Cytocentrifuge II; Shandon Southern, Sewickley, PA). Prehybridization washes, including treatment with acetic anhydride (0.1% in triethanolamine), were carried out as described (45) . Hybridization was carried out using DNA probes oligolabeled with biotin-I l-dUTP (Bethesda Research Laboratories [BRL], Gaithersburg, MD) using the method of Feinberg and Vogelstein (42) . 25 ul of hybridization cocktail (Amersco, Solon, OH) containing 100 ng/ml of probe in 45% formamide was layered over the specimen which was then covered with a glass slide, sealed in parafilm, and then hybridized for 18 h at 37°C.
Posthybridization washes were carried out as described by Lum (45) , the final wash being carried out in 0.16% SSC at room temperature. DNA-RNA hybrids were detected by the addition of a streptavidinbiotin-alkaline phosphatase conjugate that catalyzed the hydrolysis of the chromogens nitroblue tetrazolium and 5-bromo-4-chloro-3-indoylphosphate (DNA detection kit; BRL, Gaithersburg, MD). Positive reactions consisted of a purple-to-deep brown-colored precipitate in the cell's cytoplasm. The degree of hybridization correlates directly with the amount of precipitate accumulated in the cell.
Hybridization with pBR322 was carried out as a negative control. An additional control consisted of pretreating specimens with RNase A (500 ,gg/ml) before hybridization with the probe of interest. Hybrid- 1478 Gewirtz, Calabretta, Rucinski, Niewiarowski, and Xu ization with a cDNA coding for human /3 actin was used as a positive control.
Reactions were semiquantitated by computer assisted microspectrophotometry (Zonax; Carl Zeiss, Mineola, NY) as a function of light transmission through the object cell. The photometer was standardized so that light transmission through a clear area ofthe slide containing no cells (background) was defined as 100% transmission, whereas no light falling on the photometer was defined as 0% transmission. Identical gain and high voltage setting were used throughout. Because increasing amount of hybridization correlates directly with the density of dye accumulation in a given cell, and increasing dye accumulation impedes light transmission through any given cell being examined, it follows that those cells that allow the greatest degree of light transmission are expressing the least amount of message.
Plasmids. Plasmids containing the cDNA inserts used as probes in these experiments have been previously described. pUC9 carrying the human coagulation Factor V (FV) gene probe was the kind gift of Dr. William Kane Preparation ofPF4 and /3-TG. synthesis ofsynthetic COOH-terminal PF4 and fl-TG peptides. Human PF4 was purified essentially as published (54) using heparin-agarose affinity chromatography. Fractions eluted from the columns were pooled and then stored lyophilized. Such preparations gave a single band on SDS-polyacrylamide gels, and were judged to > 95% pure.
Native, highly purified ,B-TG was the kind gift of Dr. Duncan Pepper, Scottish National Blood Transfusion Service, Aberdeen, Scotland.
Synthetic PF4 and ,B-TG peptides were commercially synthesized and purified (Peninsula Laboratories, Belmont, CA). Purity and sequence were confirmed by the Macromolecular Analysis and Synthesis Laboratory, Temple University School of Medicine, by Edman degradation using Applied Biosciences instrumentation. The PF4 peptides used consisted of either the terminal 13 (amino acid residues 58-70), or terminal 24 amino acids (residues 47-70) in the 70-amino acid human PF4 sequence. They were designated short and long PF4 peptide, respectively. The ,B-TG peptide consisted of the terminal 18 amino acid residues (residues 68-85).
PF4, fl-TG, and synthetic peptides were added to the cultures dissolved in alpha medium (0.5-1.0 gg/,ul), replacing an equal volume of unsupplemented alpha medium so that final culture volumes in all cases were equal.
Statistical analysis. Statistical significance of differences between groups was tested using a two-tailed t test.
Results
Effect ofpurified PF4 and 13-TG on in vitro megakaryocytopoiesis. To determine if PF4 could modify megakaryocyte colony formation in vitro, we first added various amounts of purified human PF4 to unseparated marrow MNC. To emulate basal growth conditions in marrow, the cultures contained no exogenous source of growth factors, and were supplemented only with normal human AB serum derived from platelet-poor plasma. Five experiments of this type were performed, with a total of 18 dishes per condition. In the control plates, which contained no PF4, a mean of 1 1 ± 1 (±SD) colonies per 2 X 1O' MNC plated were enumerated. In the presence of 2.5 ,ug/ml ofPF4, 7±3 colonies were counted, but this decrement was not significant (P = 0.163). In contrast, when PF4 was added to the cultures at a final concentration of 25 ug/ml, 5±3 colonies were enumerated, a 55% decrease that was highly significant (P = 0.007).
We then asked if the results obtained were mediated indirectly as a result of PF4-T lymphocyte interactions. To address this question, we compared the numbers of megakaryocyte colonies arising in cultures of adherent monocyte and T lymphocyte-depleted marrow mononuclear cells (A-T-MNC), with colonies arising in A-T-MNC to which had been added either autologous Leu 3+ helper (T4), or Leu 2+ and (T8) suppressor T cells alone, or in combination with native PF4 at concentrations of 2.5 or 25 ,ug/ml (Table I) . Coculturing target cells with either nonactivated helper, or suppressor cells, with or without low concentrations (2.5 ,ug/ml) of PF4, had no significant effect on megakaryocyte colony formation when compared to growth of target cells alone. However, the addition of high concentration of PF4 (25 ,g/ml) resulted in a highly significant decrement in colony formation, regardless of the lymphocyte subtype that was added to the cultures (Table I).
The results recorded in Table I suggested that the colony suppressive effect of PF4 was independent of its effects on T lymphocytes, and might have been exerted directly on the megakaryocyte colony forming cells. This hypothesis was tested by culturing A-T-MNC with purified human PF4 under simulated basal marrow growth conditions (Fig. 1 A) . ,ug/ml) could still inhibit in vitro megakaryocytopoiesis in the wdepleted of ad-presence of exogenous colony stimulators (Fig. 1 B) . rH IL 3 as detailed in(ad 20 U/ml), and rH GM-CSF (-5 ng/ml) were therefore pensions of the added to the cultures in addition to the PF4 preparations. vere then culThree experiments were performed; one with native protein, nce of recombiand two with long peptide. In each, significant inhibition of ig/ml). Each line colony formation was observed. The degree of inhibition in d in duplicate or each was similar, being 55% with the native protein, and 71 ean±SD) in the and 49% with the long peptide (average = 58%). The effect of op to bottom rehighly purified ,B-TG on megakaryocyte colony formation was 1.8 vs. 5.2.1 also assessed under these growth conditions. In contrast to the ut with native results with the PF4 preparations, and similar to the results in .010; the other the basal cultures, no effect on colony formation was observed. itide (25 ,ug/ml).
Finally, to determine lineage specificity of the PF4 effect, 68.8±7.6 (P we tested the ability of purified human PF4 protein to inhibit CFU-E, and CFU-GM-derived colony formation. As shown in Fig. 2 tion, but in two Studies on the mechanism of PF4-induced inhibition of formation that megakaryocytopoiesis. If one considers potential mechanisms Fig. 1 A) .
for the observed decrement in megakaryocyte colony formad ,-TG peptides tion in the presence of PF4, the most proximate would include Le Light-density marrow MNC were depleted of adherent monocyte-macrophages and T lymphocytes, and then cloned in plasma clot cultures as described in Methods. Short (13 amino acid residues) and long (24 amino acid residues) synthetic PF4 peptides were then added to the cultures in dose-response fashion and resulting megakaryocyte colonies enumerated as described. (37) . Normal, mature human megakaryocytes were isolated from bone marrow by centrifugal elutriation, and suspended for up to 24 h in liquid cultures containing synthetic long PF4 peptide. The cells were then fixed as described above and probed for the expression of FV mRNA by the technique of in situ hybridization using a biotinylated cDNA probe. Results of a typical experiment are shown in a composite photomicrograph (Fig. 3, A-F) . Cells in A were hybridized with a pBR322 probe and are unlabeled. In B, cells were probed with an insert for human , actin and are strongly labeled. This signal is essentially eliminated by pretreating cells with RNase (500 ,gg/ml) before hybridization as shown in C. D and E show typical signal achieved after hybridization with the FV cDNA probe. F demonstrates the marked reduction in signal noted after incubation in 100 ig/ml PF4 for 16-18 h. Comparable decreases in FV mRNA were found when megakaryocytes were exposed to concentrations of long PF4 peptide as low as 100 ng/ml. At 20 ng/ml the effect was no longer detectable. In contrast to these results, the synthetic f3-TG peptide caused no discernible decrease in FV mRNA levels at concentrations up to 10 jig/ml, a dose well in excess of that at which long PF4 peptide exerted significant effects on FV mRNA levels.
To objectify our results, accumulation of indicator dye in megakaryocytes posthybridization was semiquantitated by microspectrophotometry (see Methods). It should be emphasized that since the photometer is not as sensitive to grey scale changes within a color family as it is to black and white, differences recorded are underestimates of true changes observed (see Fig. 3 ).
Light transmission through mononuclear cells was found to be quite constant after hybridization with the FV probe, regardless of the conditions under which the cells were cultured. MNC in the control suspension cultures (n = 228) were found to allow 73.2±7.5% light transmission (100% maximum), whereas similar cells exposed to 100 jig/mi of synthetic PF4 peptide permitted 72.8±7.8% light transmission (n = 216). These differences were of no statistical significance (P = 0.559). In contrast, light transmission through megakaryocytes incubated in PF4 was 64.4±8.4% posthybridization (n = 292) with the FV cDNA probe, versus 58±9.5% in the control cells (n = 298). This difference, while small in absolute terms, was highly significant (P < 0.001). If the change in light transmission in these groups is compared with that permitted by the unlabeled MNC it is calculated that control megakaryocytes had 60% greater dye accumulation than cells incubated in PF4 [73-64% = A9; 73-58% = A15; 9/15 = 0.6]. These data are indicative ofa highly significant decline in FV mRNA after exposure to PF4. It is unlikely that this decrement was due to a toxic effect of the PF4 preparation because similarly prepared COOH-terminal fl-TG peptide had no effect on FV mRNA levels, and the c-myc message, which is known to have a very short half-life (55), was still highly expressed in cells cultured under both control and experimental conditions (data not shown).
Potential molecular mechanism(s) for the biological effects of PF4 described above were explored by examining the effect of PF4 on expression of genes whose products have been linked to cell growth and differentiation. The genes chosen for analysis were p53, histone H3, c-myc, and c-myb. Histone H3 and p53 are known to be expressed in greater amounts in proliferating as opposed to quiescent cells (40) . Expression of c-myc and c-myb have also been related to cell growth, and maturation (56, 57) . The human leukemia cell line HEL was used as an indicator system for these studies as it is not currently possible to obtain sufficient numbers of enriched megakaryocyte progenitor cells to conduct this type of experiment. HEL cells are known to express several phenotypic markers characteristic of early megakaryocytes such as platelet glycoproteins and platelet-derived growth factor (PDGF) (58) and were therefore used as a model for studying early megakaryocyte proliferation and maturation related events.
As shown in Fig. 4 , when HEL cells in log phase growth are exposed to high concentrations of PF4, there was no appreciable change in expression of histone H3 at any of the times tested when compared with time 0. Similarly, there is clearly no downregulation of p53, and in fact the autoradiogram suggests a slight induction in the level of p53 expression. These results are concordant with the colony data described above and again suggest that PF4 exerts minimal antiproliferative effects on cells it contacts.
Expression levels of the protooncogenes c-myc and c-myb in the presence or absence of PF4 are shown in Figs. 5 and 6. Exposure of HEL cells in log phase growth to 50 jug/ml of purified PF4 protein was associated with a clearly identifiable increase in c-myc expression at both 2 and 12 h in comparison to the time 0 control (Fig. 5) . No change in expression ofthese genes over 24 h was observed in HEL cells not exposed to PF4.
Exposure of HEL cells to the 100 ,ug/ml of long synthetic PF4 peptide was also found to effect protooncogene expression, resulting in a two-to fourfold increase in c-myb expression at 2 and 12 hours (Fig. 6) . In contrast, ,32-microglobulin gene expression was unaffected at these same time points.
Discussion
We initially became interested in PF4 when Katz et al. reported that platelet alpha granule releaseates could augment the immune response of SJL mice to foreign antigens, and reverse lymphoma or allogeneic T lymphocyte-induced immunosuppression (33, 34) . The responsible factor was subsequently identified as PF4. Because several groups have reported that helper T lymphocytes can augment megakaryocytopoiesis (59, 60 ) the addition of PF4 to our cultures might have augmented colony formation. Alternatively, because our own studies with T lymphocytes (and subsets) suggest that non-activated cells have little impact on megakaryocytopoiesis (12), we believed that no change in colony formation might also be observed. Therefore, we were surprised that PF4 inhibited megakaryocyte colony formation. Further experiments suggested that the suppressive effect observed did not require the cooperation of T lymphocytes (Table I) , and was likely due to a direct effect on cells of the megakaryocyte lineage (Fig. 1) . Because PF4 is synthesized by megakaryocytes, and binds to platelets (and presumably megakaryocytes) in a reversible and saturable manner (Kd 2.7 X 108 M) (27) , it fulfills all criteria as a genuine autocrine regulator (61) . In support of this concept, PF4 does not bind to erythrocytes (31) and has no effect on erythroid colony formation (Fig. 2) . These results contrast in an important way with the more general inhibition of hematopoiesis reported to be caused by TGF-# (18) .
The possibility that residual impurities, or another contaminating platelet protein in the PF4 preparation might have been responsible for the diminution in colony formation was c-myc- explored by testing two synthetic COOH-terminal PF4 peptides in an identical bioassay. A short peptide consisting of the last thirteen amino acids of the carboxy terminus appeared to have less consistent colony inhibitory activity than a long peptide consisting of the last 24 amino acids of this region (Table   II) . The latter significantly (P < 0.05) inhibited colony formation in all four experiments performed. The degree of inhibition varied but was always > 50% with a mean (±SD) of 69±14%.
To understand why colony inhibition varied with the PF4 preparation used, we deduced the predicted structure of the PF4 peptides used. A Chou and Fasman type analysis was used (62) , with the constraint that the total number of residues in each configuration agree with the totals deduced from the observed circular dichroism spectra (63) . Comparison of the synthetic peptides' sequences suggests that the long peptide may contain two # pleated sheets, whereas the short peptide contains only one stretch of 3 pleated sheet. The long peptide also contains a cysteine residue at position 52 that could allow for the formation of dimers, whereas the absence ofthis residue in the short peptide suggests that if may exist in monomeric form only. Recent nuclear magnetic resonance data from our laboratory also suggest that the long peptide and the native protein share some helical structure in the COOH-terminal domain (64). Finally, when native PF4, and the long and short peptides are adsorbed onto a heparin-agarose column, they are eluted with 1.2, 0.5, and 0.2 M NaCl concentrations, respectively, thereby demonstrating differential heparin binding avidity. These differences may at least partially explain why the shorter peptide had less detectable colony inhibitory activity. Regardless, these data suggest that the inhibitory effect may be localizable to the carboxy-terminal domain of PF4. Whether other portions of the molecule have similar or greater activity remains to be determined. They also suggest that biologic effects discerned are not due to the strong positive charge of the PF4 molecule. If charge alone were responsible for the effects observed, then one would have seen greater inhibition with the synthetic peptides, as they bear much greater charge than the purified native protein.
We then performed several types of analysis designed to determine potential mechanisms for the colony inhibitory effect. First, if one considers potential mechanisms of action of this protein, inhibition might be effected by suppressing progenitor cell proliferation, and/or by imposing a block in the maturation of either late progenitor, or early megakaryocyte precursor cells. Analysis of a total of three hundred colonies grown in the presence or absence of PF4 revealed a modest (-33%), though statistically significant decline in the total number of cells/colony in the presence of PF4 (Table III) . This result suggested that PF4 had only minor effects on cells in the proliferative compartment. This interpretation was supported by the finding that, regardless of culture conditions, the numbers of small, immature cells per colony did not appear to differ in a meaningful way (Table III) . Because these small cells either include, or are the immediate progeny of, cells in the proliferative compartment, one would have expected differences in their number had PF4 exerted an effect at this level. Further, when we compared the numbers oflarge, mature cells per colony, PF4 containing plates had an easily discerned decrease (-60%, P < 0.001) in these cells when compared with controls. Finally, if PF4 acted significantly on proliferating cells we would have expected an even greater decrease in colony numbers when IL 3 and GM-CSF were added to the cultures, a finding which was not observed (Fig. 1 B) . In aggregate, these data led to the hypothesis that PF4 exerted much more profound effects on megakaryocyte maturation than on progenitor cell proliferation, though we cannot exclude effects on an as yet identified subpopulation of megakaryocyte progenitor cells. Because the numbers of small cells in colonies is unaffected, whereas the number of mature large cells per colony is significantly diminished, these data suggest that a cell transitional between these types is the likely target of the PF4 inhibitory effect.
Several experimental strategies were then employed to corroborate the conclusions drawn from the cell culture experiments. First, we used the human erythroleukemia cell line HEL as a model system for testing the antiproliferative effects of PF4 on a primitive, highly proliferative cell with megakaryocytic properties. As noted in Results (Fig. 4) , exposure to PF4 did not appear to effect the expression of the cell cycle-dependent genes p53 or histone H3 as determined by Northern analysis. In addition, the doubling time of the HEL cells was not effected by adding PF4 to the culture medium (data not shown). In contrast, by using the technique of in situ hybridization we were able to demonstrate that mRNA levels of the maturation related FV gene could be downregulated by exposure to synthetic COOH-terminal long PF4 peptide at concentrations as low as 100 ng/ml. Both trypan blue exclusion, maintenance of the short-lived c-myc message in treated cells, and failure to achieve a similar result with a fl-TG synthetic peptide all strongly suggested that this effect was not due to PF4-induced cell toxicity.
In hematopoietic cells, control of cell proliferation and maturation are often linked to the expression of the growthregulated genes c-myc and c-myb. A large number of investigations have demonstrated that as these cells differentiate the levels of expression of both genes decline (65) (66) (67) (74) . Finally, FV mRNA levels are decreased by nanogram range doses of material. Accordingly, we hypothesize that PF4 may function as a negative autocrine regulator of human megakaryocytopoiesis. In this regard, it is again ofinterest that we observed less colony inhibition in cultures containing exogenously added growth factors than in those designed to emulate basal marrow growth conditions. This observation could have physiological relevance in that it suggests a potential mechanism for overriding PF4-induced inhibition. Such a phenomenon would be of great importance in situations were ongoing platelet destruction (and release of PF4) would necessarily require compensatory increases in platelet production. Alternatively, because it is known that prolonged exposure to a ligand can lead to downmodulation of receptor (75) escape from PF4 mediated inhibition might also occur in this manner in the in vivo situation just referred to. All these considerations lead us to further hypothesize that PF4 mediated inhibition may be of greater physiologic significance under homeostatic conditions. Studies aimed at providing more definitive proof of these postulates are presently ongoing in our laboratory.
